Back to search

Eptiva Therapeutics Ltd

12963941

active
Private Limited Company
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Negative net worth (-10)

Details

132 GIDLEY WAY, OXFORD, OX33 1TD
Incorporated 21/10/2020

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Mr Mark John Field

director · Since 21/10/2020

DIRECTOR

BRITISH · ENGLAND · Age 56

Mr Harald Friedrich Stock

director · Since 21/10/2020

DIRECTOR

GERMAN · UNITED STATES · Age 58

Persons with Significant Control

Mr Harald Friedrich Stock

25–50% shares
25–50% votes
Appoint directors

German · United States · Age 58

132, Gidley Way, Oxford, OX33 1TD

Notified 21/10/2020

Mr Mark John Field

50–75% shares
50–75% votes
Appoint directors

British · England · Age 56

132, Gidley Way, Oxford, OX33 1TD

Notified 21/10/2020

CompanyRankvs 2731+ SIC 72110 peers
35

Financial strength6th percentile among SIC peers · 2/25
Employees66th percentile among SIC peers · 10/15
LiquidityCurrent ratio 0.01× · 2/20
Longevity6 years trading (max 15) · 6/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength2/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees10/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity6/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/10/2025

Net Worth

-£312k

Balance sheet strength

Cash

Cash in the bank

Net Current Assets

-£312k

Working capital

Current Assets

£3k

Current Liabilities

£316k

2avg. employees

Balance Sheet

Assets less current liabilities-£312k
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20250.01+£0
20250.01-£126k
20240.41-£93k
20230.72-£86k
20220.60

Derived from filed accounts. Not audited figures.